Search

Your search keyword '"Merck & Company Inc. -- International economic relations"' showing total 113 results
Start Over Descriptor "Merck & Company Inc. -- International economic relations"
113 results on '"Merck & Company Inc. -- International economic relations"'

1. Germany Chemical Licensing Market Forecast 2024-2029, Featuring Mitsubishi Gas, ExxonMobil, Eastman Chemical, Dow, Merck Millipore, Valtris Specialty Chemicals, RUDOLF, Huntsman and Nova Chemicals

Subjects
Merck & Company Inc. -- International economic relations, Eastman Chemical Co. -- International economic relations, Exxon Mobil Corp. -- International economic relations, Pesticides industry -- Industry forecasts -- International economic relations, Law firms -- International economic relations -- Industry forecasts, Natural gas -- Reports, Herbicides -- Industry forecasts -- International economic relations, Plastics industry -- Industry forecasts -- International economic relations, Petroleum industry -- Industry forecasts -- International economic relations, Chemical industry -- Industry forecasts -- International economic relations, Instrument industry -- International economic relations -- Industry forecasts, Oil and gas leases -- Reports, Pharmaceutical industry -- Industry forecasts -- International economic relations, Business, Business, international
Abstract

M2 PRESSWIRE-September 16, 2024-: Germany Chemical Licensing Market Forecast 2024-2029, Featuring Mitsubishi Gas, ExxonMobil, Eastman Chemical, Dow, Merck Millipore, Valtris Specialty Chemicals, RUDOLF, Huntsman and Nova Chemicals (C)1994-2024 M2 COMMUNICATIONS [...]

Published
2024

2. OUTLOOK:Senators will consider subpoenas for pharmaceutical execs

Author

Durkin, Erin, Green, Lauren, and Athey, Philip

Subjects
Merck & Company Inc. -- International economic relations, Johnson & Johnson -- International economic relations, Microsoft Corp. -- International economic relations, Computer software industry -- International economic relations, Executives -- Political activity -- Political aspects, Pharmaceutical industry -- International economic relations, General interest, Political science
Abstract

PLUS:The FTC takes a close look at AI partnerships, and the administration draws fire over decision to delay massive LNG project in Louisiana. Pharmaceutical companies are back in the crosshairs [...]

Published
2024

3. Global Bioreactors Market Forecast Report 2024-2035 with Key Players Profiles of Applikon Biotechnology, Bionet, Cytiva, Eppendorf, Merck, Sartorius, Solaris Biotech, Solida Biotech and LABAO

Subjects
Merck & Company Inc. -- International economic relations, Biological products -- Reports, Biotechnology -- Reports, Adalimumab -- Reports, Pharmaceutical industry -- Industry forecasts -- International economic relations, General interest, News, opinion and commentary
Abstract

DUBLIN: RESEARCH AND MARKETS has issued the following news release: The 'Bioreactors Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Fabrication Material, Type of Bioprocess, Type of [...]

Published
2024

4. The trick America's biggest drug companies are using to screw over taxpayers

Subjects
Merck & Company Inc. -- International economic relations, Pharmaceutical industry -- International economic relations, Consumer news and advice, General interest
Abstract

There's a mystery lurking in America's national medicine cabinet. Americans pay the highest prices in the world for lifesaving medicines roughly triple what people in the world's other big economies [...]

Published
2023

5. Pork producers descend upon D.C. to discuss policy priorities

Subjects
Merck & Company Inc. -- International economic relations, Legislators, Pork industry -- International economic relations, Pharmaceutical industry -- International economic relations, Agricultural industry, National Pork Producers Council
Abstract

More than 100 pork producers from around the country attended National Pork Producers Council's Spring Legislative Action Conference on March 29-30 in Washington, D.C. The biannual fly-in allows U.S. pork [...]

Published
2023

6. Lessons learnt in expediting prequalification and registration of Ebola Zaire vaccine/Enseignements tires du processus accelere de prequalification et d'homologation du vaccin contre le virus Ebola Zaire

Subjects
Merck & Company Inc. -- International economic relations, Vaccines -- Health aspects, Epidemics -- United States -- Congo (Kinshasa), Public health -- Health aspects, Decision making -- Health aspects, Pharmaceutical industry -- International economic relations, Drug approval -- Health aspects, COVID-19 -- Health aspects, Government, Health, European Union, World Health Organization
Abstract

On 11 November 2019, MSD (Merck & Co., Inc., Kenilworth (NJ), USA in Canada and the USA) Ebola Zaire virus vaccine received conditional marketing authorization from the European Commission, and [...]

Published
2020

7. Bloodstream infections in critically ill patients: an expert statement

Author

Timsit, Jean-François, Ruppé, Etienne, Barbier, François, Tabah, Alexis, and Bassetti, Matteo

Subjects
Merck & Company Inc. -- International economic relations, Pfizer Inc. -- International economic relations, Blood -- Medical examination, Drug resistance in microorganisms -- Care and treatment, Fludrocortisone -- Health aspects, Infection -- Care and treatment, Methicillin -- Health aspects, Epidemiology -- Health aspects, Septic shock -- Care and treatment, Pharmaceutical industry -- International economic relations, Health care industry
Abstract

Bloodstream infection (BSI) is defined by positive blood cultures in a patient with systemic signs of infection and may be either secondary to a documented source or primary-that is, without identified origin. Community-acquired BSIs in immunocompetent adults usually involve drug-susceptible bacteria, while healthcare-associated BSIs are frequently due to multidrug-resistant (MDR) strains. Early adequate antimicrobial therapy is a key to improve patient outcomes, especially in those with criteria for sepsis or septic shock, and should be based on guidelines and direct examination of available samples. Local epidemiology, suspected source, immune status, previous antimicrobial exposure, and documented colonization with MDR bacteria must be considered for the choice of first-line antimicrobials in healthcare-associated and hospital-acquired BSIs. Early genotypic or phenotypic tests are now available for bacterial identification and early detection of resistance mechanisms and may help, though their clinical impact warrants further investigations. Initial antimicrobial dosing should take into account the pharmacokinetic alterations commonly observed in ICU patients, with a loading dose in case of sepsis or septic shock. Initial antimicrobial combination attempting to increase the antimicrobial spectrum should be discussed when MDR bacteria are suspected and/or in the most severely ill patients. Source identification and control should be performed as soon as the hemodynamic status is stabilized. De-escalation from a broad-spectrum to a narrow-spectrum antimicrobial may reduce antibiotic selection pressure without negative impact on mortality. The duration of therapy is usually 5-8 days though longer durations may be discussed depending on the underlying illness and the source of infection. This narrative review covers the epidemiology, diagnostic workflow and therapeutic aspects of BSI in ICU patients and proposed up-to-date expert statements., Author(s): Jean-François Timsit [sup.1] [sup.2], Etienne Ruppé [sup.2] [sup.3], François Barbier [sup.4], Alexis Tabah [sup.5], Matteo Bassetti [sup.6] Author Affiliations: (1) AP-HP, Hôpital Bichat, Medical and Infectious Diseases ICU, , [...]

Published
2020
Full Text
View/download PDF

8. Merck grants Sinopharm monogravir distribution rights in China

Subjects
Merck & Company Inc. -- International economic relations, Pharmaceutical industry -- International economic relations, Business, News, opinion and commentary
Abstract

Merck and Sinopharm jointly announced that they have signed a partnership agreement. According to the framework agreement, Merck will grant Sinopharm the distribution rights and exclusive import rights of monogravir, [...]

Published
2022

9. Biden administration tests vaccines to fight avian flu

Subjects
United States. Department of Agriculture -- International economic relations -- Planning, Merck & Company Inc. -- International economic relations, Avian influenza, Vaccination, Influenza vaccines -- Planning, Poultry industry -- International economic relations, Livestock farms, Pharmaceutical industry -- International economic relations, Company business planning, Business, Computers and office automation industries, Telecommunications industry
Abstract

Byline: Laura Reiley Agriculture officials in the Biden administration are testing four vaccines in hopes of stanching the latest outbreak of a highly pathogenic avian influenza that has devastated U.S. [...]

Published
2023

10. KLOBUCHAR, WELCH, COLLEAGUES FILE AMICUS BRIEF URGING COURT TO UPHOLD MEDICARE'S ABILITY TO NEGOTIATE LOWER PRESCRIPTION DRUG PRICES FOR CONSUMERS

Subjects
Merck & Company Inc. -- International economic relations, Medicare -- Prices and rates -- Political aspects, Drugs -- Prescribing -- Prices and rates -- Political aspects, Pharmaceutical industry -- International economic relations -- Political aspects, Company pricing policy, News, opinion and commentary
Abstract

WASHINGTON -- The following information was released by the office of Minnesota Sen. Amy Klobuchar: Senators Amy Klobuchar and Peter Welch as well as Senators John Hickenlooper, Elizabeth Warren, Chris [...]

Published
2023

11. LATEST COMPANY NEWS

Subjects
United States. Food and Drug Administration -- International economic relations, Merck & Company Inc. -- International economic relations, Pfizer Inc. -- International economic relations, Roche Holding (UK) Ltd. -- International economic relations, AstraZeneca PLC -- International economic relations, London Stock Exchange PLC -- International economic relations, Antineoplastic agents -- Health aspects, Endometrial cancer -- Care and treatment, Cancer -- Care and treatment, Ovarian cancer -- Care and treatment, Securities industry -- International economic relations, Pharmaceutical industry -- International economic relations, Antimitotic agents -- Health aspects, Securities industry, Business, international, Kadcyla (Medication) -- Health aspects, Lynparza (Medication) -- Health aspects
Abstract

#(1) PMLiVE - AstraZeneca/Merck's Lynparza combination recommended by NICE for advanced ovarian cancer - 8/12/2023 AstraZeneca (AZ) and Merck's, known as MSD outside the US and Canada, Lynparza (olaparib) has [...]

Published
2023

12. Merck inks pact with DAE for heavy water supply

Subjects
Merck & Company Inc. -- International economic relations, Nuclear energy, Heavy water, Water-supply -- United States, Pharmaceutical industry -- International economic relations, Business, international
Abstract

Merck Life Science has entered into a five-year partnership with Heavy Water Board, which operates under the Department of Atomic Energy (DAE) last month for the constant supply of heavy [...]

Published
2023

13. Pet Insect Repellent Market Size is projected to reach USD 24.06 Billion by 2030, growing at a CAGR of 6%: Straits Research

Subjects
Merck & Company Inc. -- International economic relations, West Nile fever, Disease transmission, Lyme disease, Pharmaceutical industry -- International economic relations, Banking, finance and accounting industries, Business
Abstract

New York, United States, June 15, 2023 (GLOBE NEWSWIRE) -- Insect repellents for pets ward off mosquitoes, ticks, flies, and other bite insects. Mosquitoes can transmit Zika virus, Malaria, and [...]

Published
2023

14. Court of Justice of the European Union (General Court) Judgment: AstraZeneca v Commission (T-321|05)

Subjects
Merck & Company Inc. -- International economic relations, Generics UK Ltd. -- International economic relations, AstraZeneca PLC -- International economic relations, Gastrointestinal agents, Generic drugs, Judgments, Pharmaceutical industry -- International economic relations, News, opinion and commentary, European Union. European Commission
Abstract

Luxembourg: Court of Justice of the European Union (General Court) has issued the following Judgment on (01 July 2010): JUDGMENT OF THE GENERAL COURT (Sixth Chamber, Extended Composition) 1 July [...]

Published
2023

15. OSE Immunotherapeutics Presents Clinical Abstracts on Tedopi[R] at the ASCO 2023 Annual Meeting

Subjects
Merck & Company Inc. -- International economic relations, Merck Sharp & Dohme Corp. -- International economic relations, Chemotherapy, Lung cancer, Non-small cell, Cancer -- Chemotherapy, Ovarian cancer, Pharmaceutical industry -- International economic relations, Business, Business, international
Abstract

Tedopi([R]) is the Company's Most Advanced Product in Clinical Development * ATALANTE-1, a Phase 3 clinical trial with positive results comparing Tedopi([R]) to chemotherapy in non-small cell lung cancer (NSCLC) [...]

Published
2023

16. Registration Of Suppliers For Chemicals: Sigma Aldrich Inc., Merck (india), Merck (imported), Loba, S.d. Fine, Rankem, Himedia Or Equivalent, Qualigens, Accustandard, Fischer Sicentific, Glasswares: Borosil, Vensil, Fluka, Plastic Wares: Tarson

Subjects
Merck & Company Inc. -- International economic relations, Plastics -- International trade, Business, international
Abstract

Tenders are invited for Registration of Suppliers for Chemicals: Sigma Aldrich Inc., Merck (India), Merck (Imported), Loba, S.D. Fine, Rankem, Himedia or equivalent, Qualigens, Accustandard, Fischer Sicentific, Glasswares: Borosil, Vensil, [...]

Published
2023

17. Imported Merck treatment could be on sale next week; Antiviral drug has been approved for emergency use but still needs to be registered with regulator

Author

Liu, Zhenzhen

Subjects
Merck & Company Inc. -- International economic relations, Pfizer Inc. -- International economic relations, Antiviral agents -- International trade, National health insurance -- International trade, Pharmaceutical industry -- International economic relations, News, opinion and commentary, Paxlovid (Medication)
Abstract

China has imported “hundreds of thousands” of boxes of Merck’s Covid-19 antiviral treatment molnupiravir and they could be available by the end of next week, a senior executive with Sinopharm [...]

Published
2023

18. Merck's COVID-19 pill to be available in Egypt's hospitals in 3 weeks: Health Ministry

Subjects
Merck & Company Inc. -- International economic relations, Hospitals -- Egypt -- United States, Coronaviruses, Pharmaceutical industry -- International economic relations, Business, international
Abstract

CAIRO -- 17 January 2022: Spokesman for the Health Ministry Hossam Abdel Ghaffar said that Egypt will receive the first batch of Coronavirus oral medicine on January 21. In a [...]

Published
2022

19. US markets end higher on Tuesday

Subjects
United States. Federal Reserve Board -- Statistics -- International economic relations, Merck & Company Inc. -- International economic relations, Travelers Companies Inc. -- International economic relations, Intel Corp. -- International economic relations, Boeing Co. -- International economic relations, Microsoft Corp. -- International economic relations, Computer software industry -- International economic relations -- Statistics -- International trade, Semiconductor industry -- International economic relations -- Statistics -- International trade, Aircraft industry -- Statistics -- International economic relations -- International trade, Property and casualty insurance industry -- Statistics -- International economic relations -- International trade, Balance of trade -- United States, Pharmaceutical industry -- Statistics -- International economic relations -- International trade, Semiconductor industry, Business, international
Abstract

The report said the trade deficit widened to $67.4 billion in December from a revised $61.0 billion in November The US markets ended higher on Tuesday following Federal Reserve Chair [...]

Published
2023

20. French Competition Authority Decision: Decision 05-D-72 of December 20, 2005 relating to practices implemented by various laboratories in the sector of parallel exports of medicinal products

Subjects
Merck & Company Inc. -- International economic relations, Pfizer Inc. -- International economic relations, Boehringer Ingelheim GmbH -- International economic relations, Novartis AG -- International economic relations, Sanofi S.A. -- International economic relations, Exports, Laboratories, News, opinion and commentary
Abstract

Paris, France: French Competition Authority has issued the following decision on (December 20, 2005): Presentation of the decision Decision Information Origin of referral Pharma-Lab, Pharmajet, Pharmadex TMC, European Trade Company [...]

Published
2023

21. China : The State Food and Drug Administration approved the import registration of Merck's new coronavirus treatment monogravir capsules

Subjects
United States. Food and Drug Administration -- International economic relations, Merck & Company Inc. -- International economic relations, Chronic kidney failure -- Drug therapy, Drug approval, Coronaviruses, Pharmaceutical industry -- International economic relations -- Imports, Business, international
Abstract

On December 29, in accordance with the relevant provisions of the Drug Administration Law, the State Food and Drug Administration conducted emergency review and approval in accordance with the special [...]

Published
2023

22. China grants conditional approval for Merck's COVID-19 drug

Subjects
Merck & Company Inc. -- International economic relations, Drug approval, Pharmaceutical industry -- International economic relations, Business, regional
Abstract

BEIJING, January 3, 2023 (Xinhua via COMTEX) -- China has activated special approval procedures and granted conditional approval for the import registration of Merck's COVID-19 treatment Molnupiravir, the National Medical [...]

Published
2023

23. China : The State Food and Drug Administration approved the import registration of Merck's new coronavirus treatment monogravir capsules

Subjects
United States. Food and Drug Administration -- International economic relations, Merck & Company Inc. -- International economic relations, Chronic kidney failure -- Drug therapy, Drug approval, Coronaviruses, Pharmaceutical industry -- International economic relations -- Imports, Business, international
Abstract

On December 29, in accordance with the relevant provisions of the Drug Administration Law, the State Food and Drug Administration conducted emergency review and approval in accordance with the special [...]

Published
2022

24. China grants conditional approval for Merck's COVID-19 drug

Subjects
Merck & Company Inc. -- International economic relations, Drug approval, Pharmaceutical industry -- International economic relations, Business, general, General interest, News, opinion and commentary
Abstract

BEIJING, December 30, 2022 (Xinhua via COMTEX) -- China has activated special approval procedures and granted conditional approval for the import registration of Merck's COVID-19 treatment Molnupiravir, the National Medical [...]

Published
2022

25. Supply Of Laboratory Items For Ntep Wing,brown Paper For Sputum Box Rap - One Side Laminated -size 70 Cm 48 Cm (approx.), Diamond Marker Pen For Marking On The Slides - Imported - 6' (15.24 Cm.) Holder With Artificial Diamond (hard Stone) Embedded At

Subjects
Merck & Company Inc. -- International economic relations, Methylene blue -- International trade, Laboratory equipment -- International trade, Laboratories -- Equipment and supplies, Business, international
Abstract

Tenders are invited for Supply of laboratory items for ntep wing,brown paper for sputum box rap - one side laminated -size 70 cm 48 cm (approx.), diamond marker pen for [...]

Published
2022

26. German CEOs plead for pragmatic China-Germany business relations

Subjects
Merck & Company Inc. -- International economic relations, Pharmaceutical industry -- International economic relations, Business, general, General interest, News, opinion and commentary
Abstract

BERLIN, November 10, 2022 (Xinhua via COMTEX) -- In a joint opinion article published on Thursday, leaders of some of Germany's top companies, including BASF and Siemens, called for a [...]

Published
2022

27. Portage Biotech Announces Clinical Trial Collaboration Agreement with Merck

Subjects
Merck & Company Inc. -- International economic relations, T cells, Biotechnology, Cancer -- Care and treatment, Clinical trials, Lung cancer, Non-small cell, Business, international, Keytruda (Medication)
Abstract

(GlobeNewswire) - Portage Biotech Inc., (NASDAQ: PRTG) (Portage or the Company), a clinical-stage immuno-oncology company developing therapies to improve patient lives and increase survival by avoiding and overcoming cancer treatment [...]

Published
2022

28. Q2 2022 Divi's Laboratories Ltd Earnings Call - Final

Subjects
Merck & Company Inc. -- International economic relations, Pfizer Inc. -- International economic relations, Public relations agencies -- International economic relations, Pharmaceutical industry -- International economic relations, Business
Abstract

Presentation OPERATOR: Ladies and gentlemen, good day and welcome to the earnings conference call of Divi's Laboratories Limited for the Q2 of financial year 2022. (Operator Instructions) Please note that [...]

Published
2021

29. Taiwan Remains Defiant Against Chinese Aggression; Sydney Reopens After 106 Days Of COVID Lockdown; Moscow Tells E.U. To Fix Ties To Avoid Gas Shortages. Aired 10-11a ET

Subjects
Cable News Network. CNN International -- International economic relations, Merck & Company Inc. -- International economic relations, Energy minerals -- Supply and demand, Fossil fuels -- Supply and demand, General interest, News, opinion and commentary
Abstract

(COMMERCIAL BREAK) [10:00:46] BECKY ANDERSON, CNN INTERNATIONAL ANCHOR: Taiwan's leader says she will not bow to Beijing as the island takes center stage in the wider clash between the United [...]

Published
2021

30. RECON: FDA CONFIRMS WIDESPREAD ADDERALL SHORTAGES; INDIA FINDS VIOLATIONS AT DRUGMAKER LINKED TO GAMBIA DEATHS

Subjects
United States. Food and Drug Administration -- International economic relations, Merck & Company Inc. -- International economic relations, Pfizer Inc. -- International economic relations, Cancer vaccines, Product shortage, News, opinion and commentary, Adderall XR (Medication)
Abstract

ROCKVILLE, MD -- The following information was released by the Regulatory Affairs Professionals Society: By Michael Mezher Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing. In Focus: US [...]

Published
2022

31. Women struggle against shortages to get vital cancer-preventing HPV vaccinations

Author

Zhang, Phoebe

Subjects
Merck & Company Inc. -- International economic relations, Vaccination, Cancer -- Prevention, Pharmaceutical industry -- International economic relations, Product shortage, News, opinion and commentary
Abstract

Surgical nurse Sophie Li has found getting protected against the human papillomavirus (HPV) a “difficult victory”. Three years ago, just before hitting the national cut-off age of 26 to receive [...]

Published
2022

32. Q1 2021 Ligand Pharmaceuticals Inc Earnings Call - Final

Subjects
Merck & Company Inc. -- International economic relations, Pharmaceutical industry -- International economic relations, Business
Abstract

Presentation OPERATOR: Good afternoon, and thank you for standing by. Welcome to the Ligand Pharmaceuticals Quarter 1 earnings call. (Operator Instructions) I would now like to hand the conference over [...]

Published
2021

33. Covid-19 pill offers hope but is no magic bullet; Global supply of the much-mooted oral treatments is expected to be better than for vaccines but their success will rely on the robustness of countries’ health care systems

Author

Mccarthy, Simone Mccarthy

Subjects
Merck & Company Inc. -- International economic relations, Pfizer Inc. -- International economic relations, Vaccines, Pharmaceutical industry -- International economic relations, News, opinion and commentary
Abstract

Game-changing pills for the ­treatment of Covid-19 could soon be manufactured around the world, adding what medical experts hope will be a critical tool to blunt the sharp edge of [...]

Published
2021

34. Use of Ebola Vaccine: Expansion of Recommendations of the Advisory Committee on Immunization Practices To Include Two Additional Populations--United States, 2021

Author

Malenfant, Jason H., Joyce, Allison, Choi, Mary J., Cossaboom, Caitlin M., Whitesell, Amy N., Harcourt, Brian H., Atmar, Robert L., Villanueva, Julie M., Bell, Beth P., Hahn, Christine, Loehr, Jamie, Davey, Richard T., Sprecher, Armand, Kraft, Colleen S., Shoemaker, Trevor, Montgomery, Joel M., Helfand, Rita, Damon, Inger K., Frey, Sharon E., and Chen, Wilbur H.

Subjects
Merck & Company Inc. -- International economic relations, Vaccination -- Usage -- Health aspects, Ebola virus infections -- Prevention, Infection -- Prevention, Drug approval -- Health aspects -- Usage, Vaccines -- Usage, Medical personnel -- Usage -- Health aspects, Pharmaceutical industry -- International economic relations, Ebola virus -- Health aspects -- Usage, Virus diseases -- Prevention, Health, Ervebo (Vaccine) -- Health aspects -- Usage
Abstract

Introduction On December 19, 2019, the Food and Drug Administration (FDA) approved rVSVAG-ZEBOV-GP Ebola vaccine (ERVEBO, Merck) for the prevention of Ebola virus disease (EVD) caused by infection with Ebola [...]

Published
2022

35. Border State GOP Reps Slam 'Biden Border Crisis'; ICE Arrests Down, Border Encounters Up From January; Awaiting Biden Remarks Amid Southern Border Surge; Reports: Duchess Filed Formal Complaint After Criticism; New Fall Out From Harry And Meghan's Bombshell Interview; Lawmakers Grill Secretary Of State On China Threat; Pompeo On Biden's China Policy; Biden Speaks At White House Vaccine Event

Subjects
United States. Department of State -- International economic relations, Merck & Company Inc. -- International economic relations, FOX News Network L.L.C. -- International economic relations, Johnson & Johnson -- International economic relations, Cable television broadcasting industry -- International economic relations, Border security, Vaccines, Pharmaceutical industry -- International economic relations, General interest, News, opinion and commentary, Communist Party of China
Abstract

SANDRA SMITH, FOX NEWS ANCHOR: So much news that will affect all of us for some time to come. And finish with this, look at the Dow. An all-time high, [...]

Published
2021

36. Will New Covid Treatments Be as Elusive for Poor Countries as Vaccines?

Author

Nolen, Stephanie

Subjects
Merck & Company Inc. -- International economic relations, Vaccination, Vaccines, Coronaviruses, General interest
Abstract

Byline: Stephanie Nolen Merck has taken a step to make its antiviral pill available in poor nations, but many obstacles remain for broad access to coronavirus drugs. Nearly a year [...]

Published
2021

37. Molnupiravir seen accessible as talks with MSD on track

Subjects
Merck & Company Inc. -- International economic relations, Antiviral agents, Pharmaceutical industry -- International economic relations, Business, international
Abstract

MOLNUPIRAVIR, an oral antiviral drug clinically proven to reduce by half the risk of hospitalization or death from known variants of Covid-19, is expected to be readily available in the [...]

Published
2021

38. Merck wants Americans to pay $712 for a Covid drug that taxpayers helped develop; The drug in question only costs $17.74 to produce. Unfortunately, this type of behaviour is widespread in US pharma

Subjects
Merck & Company Inc. -- International economic relations, Drugs -- Economic aspects, Pharmaceutical industry -- International economic relations, News, opinion and commentary
Abstract

Byline: David Sirota Last week, we learned that Merck is planning to charge Americans 40 times its cost for a Covid drug whose development was subsidized by the American government. [...]

Published
2021

39. Faberco, RiteMed to bring Merck's anti-COVID oral drug Molnupiravir to PHL

Subjects
Merck & Company Inc. -- International economic relations, Antiviral agents -- Health aspects, Pharmaceutical industry -- International economic relations, Business, international
Abstract

Molnupiravir, the first oral anti-viral drug clinically proven to reduce the risk of hospitalization or death from known SARS-CoV-2 variants by half, may be available in the country as early [...]

Published
2021

40. Nigeria: Buhari Orders Minister to Submit Progress Report On Vaccine Production

Subjects
Merck & Company Inc. -- International economic relations, Biological products industry -- International economic relations, Biopharmaceutics -- Reports, Cabinet officers -- Reports, Consortia -- Reports, Vaccines -- Reports, Pharmaceutical industry -- International economic relations, Consortium, News, opinion and commentary
Abstract

Byline: Johnbosco Agbakwuru, Abuja President Muhammadu Buhari yesterday, directed the Minister of Health, Dr Osagie Ehanire, to submit a progress report by the end of May 2022 on the indigenous [...]

Published
2022

41. Full Year 2020 Nissan Chemical Corp Earnings Presentation - Final

Subjects
Merck & Company Inc. -- International economic relations, Chemical industry -- International economic relations, Pharmaceutical industry -- International economic relations, Strategic planning (Business), Finance, Business
Abstract

Presentation JUNICHI MIYAZAKI, SENIOR EVP OF CORPORATE STRATEGY & COORDINATION, CFO AND DIRECTOR, NISSAN CHEMICAL CORPORATION: [Interpreted] I am Miyazaki. Thank you for joining our financial results meeting. Please turn [...]

Published
2020

42. The development of antiviral COVID pills is a turning point in the pandemic

Author

Stoltz, Harry

Subjects
United States. Food and Drug Administration -- International economic relations -- Planning, Merck & Company Inc. -- International economic relations, Pfizer Inc. -- International economic relations, Epidemics -- United States, Mortality -- United States, Antiviral agents -- Planning, Drug approval, Pharmaceutical industry -- International economic relations, Company business planning, News, opinion and commentary, Sports and fitness, Paxlovid (Medication)
Abstract

Byline: Harry Stoltz Post Views: 230 Courtesy of Pexels On Nov. 16, the Biden administration announced its plan to purchase 10 million doses of Pfizer's new antiviral COVID pill, Paxlovid. [...]

Published
2021

43. Germany : Merck Establishes External Expert Committee for Sustainability

Subjects
Merck & Company Inc. -- International economic relations, Sustainable development, High technology industry, Pharmaceutical industry -- International economic relations, Business, international
Abstract

Merck, a leading science and technology company, has established an external expert committee for sustainability. The Merck Sustainability Advisory Panel (MSAP) consists of six independent international experts on sustainability-related topics. [...]

Published
2021

44. Outlook on the DNA Library Preparation Kits Global Market to 2026 - Featuring Illumina, Abcam and Merck Among Others

Subjects
Merck & Company Inc. -- International economic relations, DNA -- Reports, Pharmaceutical industry -- International economic relations -- Industry forecasts, Genomic libraries -- Reports, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'DNA Library Preparation Kits Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product [...]

Published
2021

45. Outlook on the DNA Library Preparation Kits Global Market to 2026 - Featuring Illumina, Abcam and Merck Among Others - ResearchAndMarkets.com

Subjects
Merck & Company Inc. -- International economic relations, DNA -- Reports, Pharmaceutical industry -- International economic relations -- Industry forecasts, Genomic libraries -- Reports, Business, Business, international
Abstract

DUBLIN -- The 'DNA Library Preparation Kits Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type' report has been added to ResearchAndMarkets.com's offering. [...]

Published
2021

46. Outlook on the DNA Library Preparation Kits Global Market to 2026 - Featuring Illumina, Abcam and Merck Among Others

Subjects
Merck & Company Inc. -- International economic relations, DNA, Pharmaceutical industry -- International economic relations -- Industry forecasts, Genomic libraries, Business, Business, international
Abstract

M2 PRESSWIRE-November 2, 2021-: Outlook on the DNA Library Preparation Kits Global Market to 2026 - Featuring Illumina, Abcam and Merck Among Others (C)1994-2021 M2 COMMUNICATIONS RDATE:02112021 The 'DNA Library [...]

Published
2021

47. Supplying Covid-19 Pills At Lower Cost Is Only Part of What Poorer Countries Need

Subjects
Merck & Company Inc. -- International economic relations, Vaccination, Vaccines, Pharmaceutical industry -- International economic relations, News, opinion and commentary
Abstract

Byline: Kelly Chibale For instance, just 6% of Africa's population has been (https://theconversation.com/want-to-know-about-vaccine-rollouts-in-africa-click-on-a-country-here-and-find-out-168621) fully vaccinated. Over 70% of high-income countries have already vaccinated more than 40% of their people. To [...]

Published
2021

48. MSF RESPONDS TO MERCK'S FILING FOR FDA EMERGENCY USE AUTHORIZATION FOR COVID-19 DRUG

Subjects
United States. Food and Drug Administration -- International economic relations, Merck & Company Inc. -- International economic relations, Generic drugs -- Usage, Antiviral agents -- Usage, Drug approval -- Usage, News, opinion and commentary
Abstract

NEW YORK -- The following information was released by Doctors Without Borders/Medecins Sans Frontieres (MSF): If approved, first COVID-19 antiviral pill molnupiravir could have big impact. But it will need [...]

Published
2021

49. German shares gain 0.71 pct at start of trading on Wednesday

Subjects
Merck & Company Inc. -- International economic relations, Sartorius Corp. -- International economic relations, Stocks -- Prices and rates, Building materials industry -- International economic relations, Pharmaceutical industry -- International economic relations, Business, general, General interest, News, opinion and commentary
Abstract

BERLIN, September 29, 2021 (Xinhua via COMTEX) -- German shares were off to a good start on Wednesday, with the benchmark DAX index rising 108.44 points, or 0.71 percent, opening [...]

Published
2021

50. German shares lose 0.71 pct as Thursday trading begins

Subjects
Merck & Company Inc. -- International economic relations, Stocks -- Planning, Pharmaceutical industry -- International economic relations, Aircraft engine industry -- International economic relations, Company business planning, Business, general, General interest, News, opinion and commentary
Abstract

BERLIN, September 9, 2021 (Xinhua via COMTEX) -- German shares were off to a bad start on Thursday, with the benchmark DAX index losing 110.88 points, or 0.71 percent, opening [...]

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results